Doctor Newsletter

In the lead article of our winter edition, Dr Varsha Sivalingam explores the importance of maintaining vigilance for measles amid rising global cases and ongoing local transmission. Dr Linda Dreyer outlines how QuantiFERON testing supports the detection of latent tuberculosis infection and informs targeted screening in at-risk populations. Dr Emma Goeman provides an overview of Clinical Labs' transition to EUCAST antibiotic susceptibility testing across VIC, QLD, NSW and the ACT, including updated classifications and dosing-aligned reporting. The issue concludes with an article by Professor Jane Munro, paediatric rheumatologist at the Royal Children’s Hospital, Melbourne, and Director of the Victorian Children’s Clinic, highlighting the importance of effectively managing needle pain in children using evidence-based strategies to reduce distress and improve healthcare experiences.  

VIC/QLD NSW/ACT SA/NT WA

In the lead article for our autumn edition, Dr Catherine Uzzell and Kerryn Jones (FASC, CCS) present a clinical guide to Navigating the National Cervical Screening Program, covering HPV testing, risk‑based management and patient‑specific screening decisions. Associate Professor Chris Barnes reviews the limitations of serum and Active B12 testing and outlines a clinically aligned approach to detecting functional vitamin B12 deficiency following the 2025 MBS changes. This issue concludes with an article by Dr David Deam, providing guidance for GPs on the use of high‑sensitivity troponin testing in suspected acute coronary syndromes.  

VIC/QLD/SA/NT NSW/ACT WA